Sara Mertz

1.5k total citations
29 papers, 1.2k citations indexed

About

Sara Mertz is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Sara Mertz has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Immunology. Recurrent topics in Sara Mertz's work include Respiratory viral infections research (19 papers), Influenza Virus Research Studies (7 papers) and Congenital Diaphragmatic Hernia Studies (7 papers). Sara Mertz is often cited by papers focused on Respiratory viral infections research (19 papers), Influenza Virus Research Studies (7 papers) and Congenital Diaphragmatic Hernia Studies (7 papers). Sara Mertz collaborates with scholars based in United States, Finland and Netherlands. Sara Mertz's co-authors include Joan E. Durbin, Russell K. Durbin, Emilio Flaño, Nancy A. Jewell, Asunción Mejías, Octavio Ramilo, R. Stokes Peebles, Teresa R. Johnson, Melissa Moore‐Clingenpeel and Barney S. Graham and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Journal of Virology.

In The Last Decade

Sara Mertz

29 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Mertz United States 17 873 496 323 299 109 29 1.2k
Tatiana Chirkova United States 18 826 0.9× 215 0.4× 273 0.8× 336 1.1× 73 0.7× 25 991
Rachael M. Liesman United States 10 522 0.6× 168 0.3× 310 1.0× 169 0.6× 150 1.4× 24 854
P. L. Ogra United States 15 449 0.5× 319 0.6× 265 0.8× 188 0.6× 96 0.9× 19 890
Alan M. Jewell United States 17 935 1.1× 137 0.3× 450 1.4× 320 1.1× 55 0.5× 20 1.1k
Ahmed Sabbah United States 8 347 0.4× 593 1.2× 184 0.6× 105 0.4× 398 3.7× 10 1.0k
Albert Van Geelen United States 16 417 0.5× 169 0.3× 261 0.8× 120 0.4× 132 1.2× 27 908
Chin‐Fen Yang United States 16 1.1k 1.3× 284 0.6× 585 1.8× 132 0.4× 118 1.1× 20 1.2k
Erich V. Scheller United States 13 611 0.7× 542 1.1× 191 0.6× 134 0.4× 222 2.0× 17 1.2k
Leon de Waal Netherlands 17 607 0.7× 211 0.4× 441 1.4× 172 0.6× 88 0.8× 35 987
Alfonsina Trento Spain 10 966 1.1× 137 0.3× 480 1.5× 380 1.3× 59 0.5× 13 1.1k

Countries citing papers authored by Sara Mertz

Since Specialization
Citations

This map shows the geographic impact of Sara Mertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Mertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Mertz more than expected).

Fields of papers citing papers by Sara Mertz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Mertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Mertz. The network helps show where Sara Mertz may publish in the future.

Co-authorship network of co-authors of Sara Mertz

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Mertz. A scholar is included among the top collaborators of Sara Mertz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Mertz. Sara Mertz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nehar-Belaid, Djamel, Asunción Mejías, Zhaohui Xu, et al.. (2025). SARS-CoV-2 induced immune perturbations in infants vary with disease severity and differ from adults’ responses. Nature Communications. 16(1). 4562–4562. 2 indexed citations
2.
Tang, Li, Ki Wook Yun, Zhaohui Xu, et al.. (2024). Nasal Mucosal Cytokines as Potential Biomarkers for Assessing Disease Severity and Class of Pathogen in Children With Community-Acquired Pneumonia. The Journal of Infectious Diseases. 231(4). 1031–1040. 2 indexed citations
3.
Nouri, Nima, Eleonora Bunsow, Djamel Nehar-Belaid, et al.. (2023). Young infants display heterogeneous serological responses and extensive but reversible transcriptional changes following initial immunizations. Nature Communications. 14(1). 7976–7976. 7 indexed citations
4.
García-Mauriño, Cristina, Melissa Moore‐Clingenpeel, Zhaohui Xu, et al.. (2022). Type III Interferons, Viral Loads, Age, and Disease Severity in Young Children With Respiratory Syncytial Virus Infection. The Journal of Infectious Diseases. 227(1). 61–70. 17 indexed citations
5.
Bline, Katherine, Melissa Moore‐Clingenpeel, Sara Mertz, et al.. (2022). Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19. Frontiers in Pediatrics. 10. 893045–893045. 4 indexed citations
6.
Mertz, Sara, Fang Ye, Mark W. Hall, et al.. (2021). Severe Acute Respiratory Syndrome Coronavirus 2 RNAemia and Clinical Outcomes in Children With Coronavirus Disease 2019. The Journal of Infectious Diseases. 225(2). 208–213. 4 indexed citations
7.
Díaz, Alejandro, Eleonora Bunsow, Cristina García-Mauriño, et al.. (2021). Nasopharyngeal Codetection of Haemophilus influenzae and Streptococcus pneumoniae Shapes Respiratory Syncytial Virus Disease Outcomes in Children. The Journal of Infectious Diseases. 225(5). 912–923. 28 indexed citations
8.
Heinonen, Santtu, Victoria M. Velazquez, Fang Ye, et al.. (2020). Immune profiles provide insights into respiratory syncytial virus disease severity in young children. Science Translational Medicine. 12(540). 46 indexed citations
9.
García-Mauriño, Cristina, Melissa Moore‐Clingenpeel, Sara Mertz, et al.. (2020). 131. The Protective Role of Mucosal Interferons in Infants with Respiratory Syncytial Virus (RSV) Infection. Open Forum Infectious Diseases. 7(Supplement_1). S195–S196. 1 indexed citations
10.
Chang, Sheng‐Wei, Xiaoli Zhang, Rachael E. Rayner, et al.. (2018). The psychoactive substance of cannabis Δ9-tetrahydrocannabinol (THC) negatively regulates CFTR in airway cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 1862(9). 1988–1994. 6 indexed citations
11.
García-Mauriño, Cristina, Melissa Moore‐Clingenpeel, Jessica Thomas, et al.. (2018). Viral Load Dynamics and Clinical Disease Severity in Infants With Respiratory Syncytial Virus Infection. The Journal of Infectious Diseases. 219(8). 1207–1215. 61 indexed citations
12.
Smith, B. G., Eleonora Bunsow, Santtu Heinonen, et al.. (2017). Interferon gene expression as marker of immune maturation and response to vaccination. Open Forum Infectious Diseases. 4(suppl_1). S61–S61. 1 indexed citations
13.
Bunsow, Eleonora, Santtu Heinonen, Sara Mertz, et al.. (2016). The Development of the Immune System in Early Life and Its Response to Vaccination: A System Analysis Approach. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations
14.
Suárez, Nicolás M., Gerlinde Obermoser, Santiago M. C. Lopez, et al.. (2014). Differences in Antibody Responses Between Trivalent Inactivated Influenza Vaccine and Live Attenuated Influenza Vaccine Correlate With the Kinetics and Magnitude of Interferon Signaling in Children. The Journal of Infectious Diseases. 210(2). 224–233. 59 indexed citations
15.
Mertz, Sara, et al.. (2013). Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model. Antiviral Research. 99(2). 188–195. 19 indexed citations
16.
Jewell, Nancy A., Troy Cline, Sara Mertz, et al.. (2010). Lambda Interferon Is the Predominant Interferon Induced by Influenza A Virus Infection In Vivo. Journal of Virology. 84(21). 11515–11522. 220 indexed citations
17.
Jewell, Nancy A., et al.. (2007). Type I Interferon Inhibition and Dendritic Cell Activation during Gammaherpesvirus Respiratory Infection. Journal of Virology. 81(18). 9778–9789. 24 indexed citations
18.
Jurcisek, Joseph A., et al.. (2005). Chinchilla and Murine Models of Upper Respiratory Tract Infections with Respiratory Syncytial Virus. Journal of Virology. 79(10). 6035–6042. 35 indexed citations
19.
Durbin, Joan E., Teresa R. Johnson, Russell K. Durbin, et al.. (2002). The Role of IFN in Respiratory Syncytial Virus Pathogenesis. The Journal of Immunology. 168(6). 2944–2952. 152 indexed citations
20.
Durbin, Russell K., Sara Mertz, Antonis E. Koromilas, & Joan E. Durbin. (2002). PKR Protection Against Intranasal Vesicular Stomatitis Virus Infection Is Mouse Strain Dependent. Viral Immunology. 15(1). 41–51. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatiana Chirkova Breakdown of academic impact, for papers by Rachael M. Liesman Breakdown of academic impact, for papers by P. L. Ogra Breakdown of academic impact, for papers by Alan M. Jewell Breakdown of academic impact, for papers by Ahmed Sabbah Breakdown of academic impact, for papers by Albert Van Geelen Breakdown of academic impact, for papers by Chin‐Fen Yang Breakdown of academic impact, for papers by Erich V. Scheller Breakdown of academic impact, for papers by Leon de Waal Breakdown of academic impact, for papers by Alfonsina Trento
Rankless by CCL
2026